PostEra
YC W20 · Active · Medicinal Chemistry powered by Machine Learning
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW15 | |
| AI | Active | YCS25 | |
| AI | Active | YCS15 | |
| AI | Inactive | YCW23 | |
| AI | Acquired | YCS20 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW23 | |
| AI | Active | YCW22 | |
| AI | Active | YCS21 | |
| AI, Devtools | Acquired | YC +1W20 | |
| Other | Active | YCS20 |
Also from W20 in AI
All of W20About PostEra
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.
- YC batch
- W20 · Winter 2020
- Status, per YC
- Active
- Category
- AI
- Team size
- 40
- Location
- Boston, MA, USA
- Checked
- 32m ago
YC tags: AI-powered Drug Discovery, Machine Learning, COVID-19
PostEra: questions
Which YC batch was PostEra in?
PostEra was in Y Combinator's Winter 2020 batch (W20).
Is PostEra still active?
Y Combinator lists PostEra as active.
Where is PostEra based?
PostEra lists Boston, MA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.